PGI7 COST-EFFECTIVENESS OF PEGINTERFERON ALFA-2A (40KD) (PEGASYS®) COMPARED TO LAMIVUDINE AS FIRST LINE TREATMENT OF CHRONIC HEPATITIS B (CHB) IN THE UK

Nov 1, 2005, 00:00 AM
10.1016/S1098-3015(10)67514-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)67514-6/fulltext
Section Title :
Section Order : 86
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67514-6&doi=10.1016/S1098-3015(10)67514-6
HEOR Topics :
Tags :
Regions :